Namibia Business News API

{
    "totalArticles": 18166,
    "articles": [
        {
            "id": "5d518b77f68dda74177d9374e96b51e3",
            "title": "Ondas Holdings Stock (ONDS) Opinions on Record Earnings Surge",
            "description": "Earnings Breakthrough: Social media conversations center on Ondas Holdings' latest quarterly results",
            "content": "Earnings Breakthrough: Social media conversations center on Ondas Holdings' latest quarterly results, which revealed a dramatic 1,079 percent jump in revenues. Investors note the company's substantial $457 million backlog as evidence of sustained mom... [4527 chars]",
            "url": "https://www.quiverquant.com/news/Ondas+Holdings+Stock+%28ONDS%29+Opinions+on+Record+Earnings+Surge",
            "image": "https://www.quiverquant.com/images/onds_rect_new.png",
            "publishedAt": "2026-05-16T14:05:00Z",
            "lang": "en",
            "source": {
                "id": "f3cdea23e2904f71c5ab9388b4133bf1",
                "name": "Quiver Quantitative",
                "url": "https://www.quiverquant.com"
            }
        },
        {
            "id": "919fc9c886b76724cf06bae286403af3",
            "title": "The Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance",
            "description": "In the past quarter, 10x Genomics, Inc. reported first‑quarter 2026 revenue of US$150.84 million, down from US$154.88 million a year earlier, while reducing its net loss to US$13.47 million and basic loss per share to US$0.10.\nThe results, which combined a slight sales decline with a meaningfully smaller loss, have sharpened attention on how the company balances growth investments with funding and pricing pressures in the research market.\nAgainst this backdrop of lower revenue but improved...",
            "content": "Advertisement\nUnited States\n/\nLife Sciences\n/\nNasdaqGS:TXG\nThe Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance\nMay 16, 2026\nIn the past quarter, 10x Genomics, Inc. reported first‑quarter 2026 revenue o... [6428 chars]",
            "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/the-bull-case-for-10x-genomics-txg-could-change-following-mi",
            "image": "https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000",
            "publishedAt": "2026-05-16T13:57:09Z",
            "lang": "en",
            "source": {
                "id": "5ad034d710ff74cbf858f6cb83ddc3ca",
                "name": "simplywall.st",
                "url": "https://simplywall.st"
            }
        },
        {
            "id": "18398ded1c09b7560ead968d4c3f3acb",
            "title": "Cisco is the most overbought stock in the S&P 500. Here are the others.",
            "description": "Cisco was the most overbought stock in the S&P 500 this week, meaning its shares could be due for a pullback, according to a CNBC Pro screener.",
            "content": "As earnings season continues, investors have opportunities to profit off the big bounces — or avoid the pullbacks — in stocks in the wake of these quarterly reports. It's been a volatile week. The S & P 500 rallied to a record intraday high of 7,501.... [2097 chars]",
            "url": "https://www.cnbc.com/2026/05/16/cisco-is-the-most-overbought-stock-in-the-sp-500-here-are-the-others.html",
            "image": "https://image.cnbcfm.com/api/v1/image/108185657-1755118736019-gettyimages-2229984514-_73a6879_zqr4tdoz.jpeg?v=1770920772&w=1920&h=1080",
            "publishedAt": "2026-05-16T13:17:24Z",
            "lang": "en",
            "source": {
                "id": "32c2ad3fb41cb87b5b847d750028dff0",
                "name": "CNBC",
                "url": "https://www.cnbc.com"
            }
        }
    ]
}